[Ovulation inhibitors and ACTH reserve].
D015065:17-Hydroxycorticosteroids / Q000097:blood / Q000652:urine; D015068:17-Ketosteroids / Q000097:blood / Q000652:urine; D000324:Adrenocorticotropic Hormone / Q000378:metabolism*; D002986:Clinical Trials as Topic; D003276:Contraceptives, Oral / Q000494:pharmacology*; D003864:Depression, Chemical; D004967:Estrogens / Q000652:urine; D004997:Ethinyl Estradiol / Q000494:pharmacology*; D005040:Ethynodiol Diacetate / Q000494:pharmacology*; D005260:Female; D006801:Humans; D008234:Lynestrenol / Q000494:pharmacology*; D008656:Mestranol / Q000494:pharmacology*; D008797:Metyrapone; D009640:Norethindrone / Q000494:pharmacology*; D010060:Ovulation / Q000187:drug effects*; D010902:Pituitary Gland / Q000378:metabolism*; D011276:Pregnanediol / Q000652:urine; D011279:Pregnanetriol / Q000652:urine
D015065:17-Hydroxycorticosteroids; D015068:17-Ketosteroids; D003276:Contraceptives, Oral; D004967:Estrogens; D011279:Pregnanetriol; D004997:Ethinyl Estradiol; D005040:Ethynodiol Diacetate; D000324:Adrenocorticotropic Hormone; D008656:Mestranol; D011276:Pregnanediol; D008234:Lynestrenol; D009640:Norethindrone; D008797:Metyrapone
Ovulationshemmer und ACTH-Reserve.